GINA Guidelines and Biologics for Treatment of Asthma

Sande Okelo, MD, leads a discussion on the updates in the GINA 2021 report regarding difficult-to-treat and severe asthma, as well as considerations for GINA Step 4 and 5 treatment approaches.

Related Content:

Allergies, Asthma Exacerbations and Uncontrolled Asthma ManagementAsthmaPeer Exchange

First Fungal Spore Calendar Developed for Patients with Asthma, Allergies

Physician, Patient, and Partner Perspectives on AERD with Mitchell Grayson, MD, Rhonda Nelson, and Wayne Nelson

Monica Kraft, MD: Discussing Phase 3b Findings on Albuterol/Budesonide for Asthma